Publications by authors named "Frederick Duncanson"

Claim this Profile
D
Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE.
Travis B Nielsen, Paul Pantapalangkoor, Jun Yan, Brian M Luna, Ken Dekitani, Frederick Duncanson

mBio· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
Nathan P Wiederhold, Laura K Najvar, Annette W Fothergill, Dora I McCarthy, Rosie Bocanegra, Frederick P Duncanson

Antimicrob Agents Chemother· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Madurella mycetomatis is highly susceptible to ravuconazole.
Sarah Abdalla Ahmed, Wendy Kloezen, Frederick Duncanson, Ed E Zijlstra, G Sybren de Hoog

PLoS Negl Trop Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Mariana Castanheira, Frederick P Duncanson, Daniel J Diekema, Josep Guarro, Ronald N Jones

Antimicrob Agents Chemother· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Michael A Pfaller, Frederick Duncanson, Shawn A Messer, Gary J Moet, Ronald N Jones

Antimicrob Agents Chemother· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, disposition, and metabolism of bicifadine in humans.
Philip A Krieter, Mark Gohdes, Timothy J Musick, Frederick P Duncanson, William E Bridson

Drug Metab Dispos· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.
Benjamin Torum, Stan L Block, Hugo Avila, Francisco Montiel, Axel Oliva, Frederick Duncanson

Clin Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
H Furman Cantrell, Elyane E Lombardy, Frederick P Duncanson, Ephraim Katz, Joseph S Barone

South Med J· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis